| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/2006 | EP1224207B1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 02/15/2006 | EP1154767B1 Substituted stilbene compounds with vascular damaging activity |
| 02/15/2006 | EP1140064B1 Oral administration of taxoid derivatives |
| 02/15/2006 | EP1087793B1 Material for differently modifying the optical properties of different cells and device for applying this material |
| 02/15/2006 | EP1076562B1 Glucocorticoid receptor antagonists for the treatment of dementia |
| 02/15/2006 | EP1041985B1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 02/15/2006 | EP1010423B1 Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production |
| 02/15/2006 | EP1008346B1 NF-kB INHIBITORS CONTAINING BENZOQUINONE DERIVATIVES |
| 02/15/2006 | EP0998303B1 Polymer-drug conjugate for the treatment of cancer |
| 02/15/2006 | EP0871738B1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 02/15/2006 | CN1735626A Novel anticonvulsant derivative salts |
| 02/15/2006 | CN1735620A Pure levofloxacin hemihydrate and processes for preparation thereof |
| 02/15/2006 | CN1735619A Spirocyclic cyclohexane compounds |
| 02/15/2006 | CN1735618A New tricyclic derivatives as LTD4 antagonists |
| 02/15/2006 | CN1735617A Quinazoline derivatives as SRC tyrosine kinase inhibitors |
| 02/15/2006 | CN1735616A Pyrrolobenzodiazepines |
| 02/15/2006 | CN1735615A Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 02/15/2006 | CN1735614A Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
| 02/15/2006 | CN1735613A 稠合杂环化合物 Fused heterocyclic compounds |
| 02/15/2006 | CN1735612A Anti-infective agents |
| 02/15/2006 | CN1735611A CB 1 receptor inverse agonists |
| 02/15/2006 | CN1735610A Oxazoles as mGluR1 enhancer |
| 02/15/2006 | CN1735609A Diazepanes derivatives useful as LFA inhibitors |
| 02/15/2006 | CN1735603A Benzomorpholine derivatives |
| 02/15/2006 | CN1735601A Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 02/15/2006 | CN1735600A 3-phenyl-cinnoline homologue and antitumor agent containing the same |
| 02/15/2006 | CN1735599A 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 02/15/2006 | CN1735596A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1735594A Polymorphs of bicifadine hydrochloride |
| 02/15/2006 | CN1735593A Novel CB1 receptour inverse agonists |
| 02/15/2006 | CN1735441A Combination for the treatment of ADHD |
| 02/15/2006 | CN1735434A Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 02/15/2006 | CN1735418A Micelle assemblies |
| 02/15/2006 | CN1735417A Method for treating patients exposed to toxic chemical agents |
| 02/15/2006 | CN1735416A Therapeutic combination |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735414A Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 02/15/2006 | CN1735413A High concentration formulations of opioids and opioid derivatives |
| 02/15/2006 | CN1735412A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735411A Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 02/15/2006 | CN1735410A Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 02/15/2006 | CN1735409A Imidazol derivatives having affinity for alpha 2 receptors activity |
| 02/15/2006 | CN1735408A Receptor function controlling agent |
| 02/15/2006 | CN1735407A Methods of using and compositions comprising dopamine reuptake inhibitors |
| 02/15/2006 | CN1735402A Polymer composition including large ring alkatriene compound |
| 02/15/2006 | CN1735401A Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 02/15/2006 | CN1735400A Drug delivery system using subconjunctival depot |
| 02/15/2006 | CN1735388A Method for treating patients for radiation exposure |
| 02/15/2006 | CN1735346A Cell separation compositions methods |
| 02/15/2006 | CN1735344A Novel substituted benzimidazole dosage forms and method of using same |
| 02/15/2006 | CN1735343A Compounds for the treatment of tobacco dependence and withdrawal |
| 02/15/2006 | CN1733877A Conjugated linolic acid containing high content t10 and c12 |
| 02/15/2006 | CN1733800A Outer surface proteins, their genes, and their use |
| 02/15/2006 | CN1733792A Cyclovirobuxine extraction and purification method |
| 02/15/2006 | CN1733779A Novel phosphorus-containing prodrug |
| 02/15/2006 | CN1733773A Double(2-ethyl -3-hydroxyl-4-pyranone)copper(óÄ)complex and its uses in treating diabetes |
| 02/15/2006 | CN1733769A Pyridinebenzoxazine analog quinolone derivative and its preparation method and uses |
| 02/15/2006 | CN1733767A Cyclohexanone analog saturated triring(bridge)compound and its preparation method and uses |
| 02/15/2006 | CN1733766A Cough and phlegm removing purple bergenia element analog and its pharmaceutical composition |
| 02/15/2006 | CN1733765A Purple bergenia element pentaacetylate and its uses |
| 02/15/2006 | CN1733764A 3-substituted nalidixic acid analog compound and its preparation method and uses in pharmacy |
| 02/15/2006 | CN1733761A Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and the use thereof in the production of a medicament |
| 02/15/2006 | CN1733758A Imide analog compounds and its preparation method |
| 02/15/2006 | CN1733748A Cyclohexenone analog bicyclo (condensed ring) compound and its preparation method and uses |
| 02/15/2006 | CN1733742A Phentriazine derivative preparation and uses |
| 02/15/2006 | CN1733733A Novel alkali B of cohosh root and its uses in preparing anti-myocardial ischemia drug |
| 02/15/2006 | CN1733727A Crystalline carvedilol, processes for the manufacture thereof, pharmaceutical compositions and uses thereof |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/15/2006 | CN1733717A N,N'-biacetylcysteine-diarginine salt isomer and its uses |
| 02/15/2006 | CN1733712A Myoinositol sulfate aluminium , its preparation method and oral compositions and uses |
| 02/15/2006 | CN1733708A Anti-hepatitis B virus tertiary amine oxide and preparation method and uses for manufacturing drug |
| 02/15/2006 | CN1733704A Synthesis and biological and pharmacological action of betaine salicylate |
| 02/15/2006 | CN1733699A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 02/15/2006 | CN1733693A Compound essence of Dothiorella and its preparation method and uses |
| 02/15/2006 | CN1733670A Long chain hydrocarbyl group substituted phenol chemical and its preparation method and uses |
| 02/15/2006 | CN1733314A Process for preparing cerebrose albumin magnetic adriamycin nanometer particle |
| 02/15/2006 | CN1733312A Fluorouracil-dextran and process for preparing the same |
| 02/15/2006 | CN1733310A Nanometer particle and medicine capsule of polymeric compound and preparation |
| 02/15/2006 | CN1733308A Osmotic pump controlled release formulation containing two active constituents of medicine and process for preparing the same |
| 02/15/2006 | CN1733307A Antihypertensive combination of valsartan and calcium channel blocker |
| 02/15/2006 | CN1733306A Anticancer implantation agent containing blood vessel inhibitor and guanine similarities |
| 02/15/2006 | CN1733297A Joint nutrient tablet |
| 02/15/2006 | CN1733265A Chinese traditional medicine injection for traumatology and dermatological department and process for preparing the same |
| 02/15/2006 | CN1733092A Effective ingredients of Chinese medicine moutan bark and preparation method thereof |
| 02/15/2006 | CN1733075A Tinea treating drug |
| 02/15/2006 | CN1733073A Analgesic enema liquid for children and its preparation method |
| 02/15/2006 | CN1733069A Oral cavity spray containing two effective parts of compound red sage root formula and its preparation process |
| 02/15/2006 | CN1733056A Fermented soybean and VC composite product and its preparation process |
| 02/15/2006 | CN1733050A Asiabell polysaccharide tablet of asiabell effective ingredient |
| 02/15/2006 | CN1733036A Dripping pills for dredging thrombus and preparation process thereof |
| 02/15/2006 | CN1732981A Alcohol-neutralizing agent composition containing hyaluronic acid |
| 02/15/2006 | CN1732979A Medicine for treating animal eyeball turbidness |
| 02/15/2006 | CN1732978A Externally applied medicine for treating vitiligo and its preparation process |
| 02/15/2006 | CN1732976A Hemostatic wound healing Dan |
| 02/15/2006 | CN1732975A Prescription of compound electrolyte drug for injection and method for preparing the same |
| 02/15/2006 | CN1732974A Medicinal composition of fructose diphosphate sodium and magnesium salt |
| 02/15/2006 | CN1732973A Composition containing chondroitin sulfate zinc and its application |